Researching companies, tracking transactions and sharing findings often involves moving between multiple datasets and views. This October, Biotechgate has introduced several updates designed to make those everyday workflows quicker and more straightforward.
From consolidated company information to improved deal monitoring, here are four of the latest features now available in the platform.
See the company picture in one place
The new Company Profile Overview brings key company information together in a single view.
Users can review therapeutic pipelines and active clinical trials alongside licensing activity, financing rounds and management information, making it easier to build a quick picture of a company without navigating between multiple sections.

Keep track of licensing and M&A activity
Saved searches and alerts have now been extended to license agreements and M&A transactions.
This means users can define the types of deals relevant to their work and return to those searches more easily, helping teams monitor transaction activity, potential partners or changes within particular markets over time.

Compare search results faster
Search-result tables are now sortable directly from their column headers.
Whether comparing companies, assets or transactions, users can sort results around the fields most relevant to their research rather than working through the results in their default order. It is a relatively simple change, but one designed to make larger searches significantly easier to review.

Take research beyond the platform
New PDF and print options make it easier to turn Biotechgate research into something that can be used in meetings, tradeshows or shared internally.
Users can create a company overview PDF or print selected sections of a company profile, providing a more convenient way to prepare research for discussions, reporting or colleagues who may not be working directly in the platform.

Together, these updates are intended to reduce some of the smaller steps involved in researching companies and deals, from getting an initial overview to monitoring activity and sharing the final findings.
Want to see the new features in action? Learn more with a demo from one of our team members.